From endothelial dysfunction to vascular occlusion: role of the renin-angiotensin system

Pedro Marques Silva1

  • 1Serviço de Medicina Interna, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, EPE, Lisboa, Portugal. pmarques.silva@sapo.pt

Insights

The renin-angiotensin system (RAS) significantly contributes to atherosclerosis by promoting endothelial dysfunction and inflammation. Angiotensin II (Ang II) drives plaque progression, instability, and thrombotic events, impacting cardiovascular disease.

Area of Science:

  • Cardiovascular Science
  • Vascular Biology
  • Renal Physiology

Background:

  • The renin-angiotensin system (RAS) plays a critical role in cardiovascular homeostasis.
  • Evidence links RAS activity to the development and progression of atherosclerotic disease.
  • Key components include angiotensin-converting enzyme (ACE) and angiotensin II (Ang II).

Purpose of the Study:

  • To elucidate the multifaceted role of the RAS in the pathogenesis of atherosclerosis.
  • To detail the mechanisms by which RAS components influence vascular dysfunction and plaque development.
  • To highlight the impact of Ang II on inflammatory responses and plaque stability.

Main Methods:

  • Review of existing scientific literature on RAS and atherosclerosis.
  • Analysis of studies investigating endothelial function and vascular inflammation.
  • Examination of research on Ang II's effects on vascular smooth muscle cells and plaque components.

Main Results:

  • RAS activation promotes endothelial dysfunction, an early marker of vascular disease.
  • Inflammatory cells contribute ACE and Ang II to the vascular wall, driving atherosclerotic progression.
  • Ang II stimulates vascular smooth muscle cell migration and phenotypic changes, accelerating disease.
  • Ang II modulates inflammatory responses, influencing plaque instability and thrombotic events.

Conclusions:

  • The RAS is a key mediator in the continuum of cardiovascular disease, particularly in atherosclerosis.
  • Ang II is a central player, promoting vascular damage, inflammation, plaque progression, and acute ischemic events.
  • Targeting the RAS may offer therapeutic strategies for managing atherosclerotic and cardiovascular diseases.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...